These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting. Vardarinos A; Gupta N; Janjua R; Iron A; Empeslidis T; Tsaousis KT BMC Ophthalmol; 2017 Apr; 17(1):58. PubMed ID: 28449645 [TBL] [Abstract][Full Text] [Related]
6. Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration. Barış ME; Menteş J; Afrashi F; Nalçaçı S; Akkın C Turk J Ophthalmol; 2020 Oct; 50(5):275-282. PubMed ID: 33342194 [TBL] [Abstract][Full Text] [Related]
7. AGE-RELATED MACULAR DEGENERATION-ASSOCIATED PERIPAPILLARY CHOROIDAL NEOVASCULARIZATION IN THE ERA OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Lin T; Dans K; Meshi A; Muftuoglu IK; Amador-Patarroyo MJ; Chen KC; Cheng L; Freeman WR Retina; 2019 Oct; 39(10):1936-1944. PubMed ID: 30028411 [TBL] [Abstract][Full Text] [Related]
8. IMPLICATIONS OF THE MORPHOLOGIC PATTERNS OF TYPE 1 MACULAR NEOVASCULARIZATION ON MACULAR ATROPHY GROWTH ON PATIENTS UNDER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT. Cabral D; Coscas F; Pereira T; Laiginhas R; Rodrigues C; Français C; Nogueira V; Falcão M; Miere A; Lupidi M; Coscas G; Souied E Retina; 2021 Feb; 41(2):287-295. PubMed ID: 32355125 [TBL] [Abstract][Full Text] [Related]
9. MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION. Takasago Y; Shiragami C; Kobayashi M; Osaka R; Ono A; Yamashita A; Tsujikawa A; Hirooka K Retina; 2019 Feb; 39(2):296-302. PubMed ID: 29190232 [TBL] [Abstract][Full Text] [Related]
11. Reduced Vessel Density of the Choriocapillaris during Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration. Hikichi T; Agarie M Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):1088-1095. PubMed ID: 30901385 [TBL] [Abstract][Full Text] [Related]
12. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration. Lee JY; Chung H; Kim HC Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799 [TBL] [Abstract][Full Text] [Related]
13. Subfoveal choroidal thickness predicts macular atrophy in age-related macular degeneration: results from the TREX-AMD trial. Fan W; Abdelfattah NS; Uji A; Lei J; Ip M; Sadda SR; Wykoff CC; Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):511-518. PubMed ID: 29374796 [TBL] [Abstract][Full Text] [Related]
15. Influence of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration. Kanadani TCM; Dos Reis Veloso CE; Dorairaj S; Nehemy MB Ophthalmic Res; 2017; 58(1):18-26. PubMed ID: 28301850 [TBL] [Abstract][Full Text] [Related]
16. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT. Miere A; Querques G; Semoun O; Amoroso F; Zambrowski O; Chapron T; Capuano V; Souied EH Retina; 2017 Oct; 37(10):1873-1879. PubMed ID: 28079756 [TBL] [Abstract][Full Text] [Related]
17. Assessment of Choroidal Topographic Changes by Swept-Source Optical Coherence Tomography After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration. Razavi S; Souied EH; Darvizeh F; Querques G Am J Ophthalmol; 2015 Nov; 160(5):1006-13. PubMed ID: 26275471 [TBL] [Abstract][Full Text] [Related]
18. Comparative Retinal Vessel Size Study of Intravitreal Ranibizumab and Bevacizumab in Eyes with Neovascular Age-Related Macular Degeneration. Kurt MM; Çekiç O; Akpolat Ç; Aslankurt M; Elçioğlu MN Ophthalmologica; 2017; 238(3):147-153. PubMed ID: 28601887 [TBL] [Abstract][Full Text] [Related]
19. CHANGES IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AND DISEASE ACTIVITY IN TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT. Han JW; Cho HJ; Kang DH; Jung SH; Park S; Kim JW Retina; 2020 Jul; 40(7):1245-1254. PubMed ID: 31095063 [TBL] [Abstract][Full Text] [Related]
20. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]